SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-18-014235
Filing Date
2018-03-13
Accepted
2018-03-13 07:05:14
Documents
4
Period of Report
2018-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv488278_6k.htm 6-K 10834
2 EXHIBIT 99.1 tv488278_ex99-1.htm EX-99.1 136013
3 GRAPHIC pr-1.jpg GRAPHIC 15875
4 GRAPHIC pr-2.jpg GRAPHIC 18043
  Complete submission text file 0001144204-18-014235.txt   194818
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Filer) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36345 | Film No.: 18685217
SIC: 2834 Pharmaceutical Preparations